₹175.00 3.10 (1.80%)
02:00 PM, 12-Dec-2025₹175.32 3.53 (2.05%)
01:44 PM, 12-Dec-2025BSE : 543635
NSE : PPLPHARMA
Sector : Health care
ISIN Code : INE0DK501011
Last Updated: 12-Dec-2025 | 02:00 PM IST
| Market Cap (₹ Cr) | 23,262 |
Traded Value (₹ Cr) | 12.99 |
Volume (Shares) | 7,42,261 |
Face Value (₹) | 10 |
52-Week High (₹) | 273.20 |
52-Week High Date | 31-Dec-2024 |
52-Week Low (₹) | 169.65 |
52-Week Low Date | 11-Dec-2025 |
All Time High (₹) | 307.85 |
All Time High Date | 06-Nov-2024 |
All Time Low (₹) | 61.65 |
All Time Low Date | 28-Mar-2023 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 23,304 |
| EPS - TTM (₹) [C] | -0.18 |
| P/E Ratio (X) [C] | -974.00 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 1.40 |
| Latest Dividend Date | 16-Jul-2025 |
| Dividend Yield (%) | 0.08 |
| Book Value Share (₹) [C] | 60.77 |
| P/B Ratio (₹) [C] | 2.88 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Flexi Cap Fund - (IDCW) | 1684.89 | 9,00,00,000 | 1.79 |
| HDFC Flexi Cap Fund - (G) | 1684.89 | 9,00,00,000 | 1.79 |
| HDFC Flexi Cap Fund - Direct (IDCW) | 1684.89 | 9,00,00,000 | 1.79 |
| HDFC Flexi Cap Fund - Direct (G) | 1684.89 | 9,00,00,000 | 1.79 |
| HDFC Focused Fund - Regular (G) | 509.21 | 2,72,00,000 | 1.94 |
| HDFC Focused Fund - Regular (IDCW) | 509.21 | 2,72,00,000 | 1.94 |
| HDFC Focused Fund - Direct (IDCW) | 509.21 | 2,72,00,000 | 1.94 |
| HDFC Focused Fund - Direct (G) | 509.21 | 2,72,00,000 | 1.94 |
| Bandhan Small Cap Fund (G) | 148.03 | 79,06,952 | 0.81 |
| Bandhan Small Cap Fund (IDCW) | 148.03 | 79,06,952 | 0.81 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 03-Sep-2025 | JM Financial | Buy | 313 | |
| 20-Aug-2025 | JM Financial | Buy | 295 | |
| 25-Sep-2024 | Motilal Oswal | Buy | 260 |
| Today's Low/High (₹) | 170.65 175.95 |
| Week Low/High (₹) | 169.58 182.00 |
| Month Low/High (₹) | 169.58 198.00 |
| Year Low/High (₹) | 169.58 273.00 |
| All time Low/High (₹) | 61.65 308.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -2.57% | -7.17% | -0.56% | -0.62% |
| 1 Month | -10.37% | -14.66% | 0.90% | 0.57% |
| 3 Month | -12.62% | -16.80% | 4.06% | 3.62% |
| 6 Month | -12.32% | -16.50% | 4.33% | 4.56% |
| 1 Year | -30.43% | -33.70% | 4.84% | 6.01% |
| 3 Year | 33.77% | 27.35% | 37.18% | 40.69% |
Chairperson : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : S Rama Dorai
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Non-Exec & Non-Independent Dir : Nathalie Leitch
Independent Non Exe. Director : Vibha Paul Rishi
Company Sec. & Compli. Officer : Tanya Sanish
Registered Office: Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra-400070 Ph: 91-22-3802-3000/4000
1. What's the Piramal Pharma Ltd share price today?
Piramal Pharma Ltd share price was Rs 175.00 at 02:00 PM IST on 12th Dec 2025. Piramal Pharma Ltd share price was up by 1.80% over the previous closing price of Rs 171.90. Piramal Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Piramal Pharma Ltd stock?
The performance of the Piramal Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Piramal Pharma Ltd?
Piramal Pharma Ltd has a market capitalisation of Rs 23,262 crore.
4. What is Piramal Pharma Ltd's 52-week high/low share price?
The Piramal Pharma Ltd’s 52-week high share price is Rs 273.20 and 52-week low share price is Rs 169.65.
5. Is the Piramal Pharma Ltd profitable?
On a consolidated basis, Piramal Pharma Ltd reported a loss of Rs -99.22 crore on a total income of Rs 2,124.11 crore for the quarter ended 2025.
6. Which are Piramal Pharma Ltd’s peers in the Health care sector?
Piramal Pharma Ltd’s top 5 peers in the Health care sector are J B Chemicals &, Gland Pharma, Emcure Pharma, Piramal Pharma, Astrazeneca Phar, Pfizer, Wockhardt.
7. Who owns how much in Piramal Pharma Ltd?
Key changes to the Piramal Pharma Ltd shareholding are as follows: